CIS
SBIO icon

Connors Investor Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Connors Investor Services’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.11M Buy
48,137
+6,933
+17% +$380K 0.27% 68
2026
Q1 		$2.16M Buy
41,204
+34,608
+525% +$1.76M 0.2% 85
2025
Q4 		$338K Buy
+6,596
New +$305K 0.03% 114

Other funds holding SBIO

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
FFAS
FIG Financial Advisory Services Oklahoma City, Oklahoma $171M AUM 27.06% 1-Year Est. Return

Connors Investor Services's SBIO Position: Q2 2026 in Review

Connors Investor Services increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 17% in Q2 2026, buying an estimated $380K and bringing the position to 48,137 shares worth $3.11M. The position accounts for 0.27% of the portfolio, ranked #68.

Connors Investor Services first reported a position in SBIO in Q4 2025 and has held it in 3 quarters since. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Connors Investor Services held 48,137 shares of ALPS Medical Breakthroughs ETF worth $3.11M as of Q2 2026.
  • Connors Investor Services bought 6,933 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $380K.
  • ALPS Medical Breakthroughs ETF made up 0.27% of Connors Investor Services's portfolio in Q2 2026, its #68 holding.
  • Connors Investor Services first reported a position in ALPS Medical Breakthroughs ETF in Q4 2025 and has held it in 3 quarters since.
  • 65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Connors Investor Services's 13F filing for Q2 2026, filed 14 Aug 2026.